The p53 tumour suppressor gene: A model for molecular epidemiology of human cancer

Molecular Medicine Today

Volumn 2, Issue 1, 1996, Pages 32-37

  Soussi, Thierry ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NICOTIANA TABACUM;

AFLATOXIN B1; CARCINOGEN; CYTIDYLYL 3' 5' GUANOSINE; CYTIDYLYL-3'-5'-GUANOSINE; DINUCLEOSIDE PHOSPHATE;

ANIMAL; EPIDEMIOLOGY; GENETIC MARKER; GENOME; HUMAN; LIVER CELL CARCINOMA; LUNG TUMOR; METABOLISM; MUTATION; REVIEW; SKIN TUMOR; SMOKING; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

AFLATOXIN B1; ANIMALS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; DINUCLEOSIDE PHOSPHATES; EPIDEMIOLOGY, MOLECULAR; GENES, P53; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; GENOME; HUMANS; LUNG NEOPLASMS; MUTATION; SKIN NEOPLASMS; SMOKING; ULTRAVIOLET RAYS;

EID: 0029691571     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/1357-4310(96)88756-9     Document Type: Review

References (43)

1. Tomatis, L., ed. (1990) Cancer: Causes, Occurrence and Control (IARC monographs on the evaluation of the carcinogenic risk of chemicals to Human, Vol. 10), International Agency for Research on Cancer
2. Doll, R. and Peto, R. (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today, J. Natl Cancer Inst. 66, 1192-1308
3. Harris, C.C. (1991) Chemical and physical carcinogenesis: advances and perspectives for the 1990s, Cancer Res. 51, 5023s-5044s
4. Caron de Fromentel, C. and Soussi, T. (1992) TP53 tumour suppressor gene: a model for investigating human metagenesis, Genes Chrom. Cancer 4, 1-15
5. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancers, Science 253, 49-53
6. Soussi, T. (1995) The p53 tumour suppressor gene: from molecular biology to clinical investigation, in Molecular Genetics of Cancer (Cowell, J.K., ed.), pp. 135-178, Bios Scientific
7. Kastan, M.B. et al. (1991) Participation of p53 protein in the cellular response to DNA damage, Cancer Res. 51, 6304-6311
8. Smith, M.L. et al. (1994) Interaction of the p53-regulated protein gadd45 with proliferating cell nuclear antigen, Science 266, 1376-1380
9. Yonish-Rouach, E. et al. (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6, Nature 352, 345-347
10. Lowe, S.W., Ruley, H.E., Jacks, T. and Housman, D.E. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents, Cell 74, 957-967
11. Pietenpol, J.A. et al. (1994) Sequence-specific transcriptional activation is essential for growth suppression by p53, Proc. Natl Acad. Sci. USA 91, 1998-2002
12. Lane, D. (1992) p53, guardian of the genome, Nature 358, 15-16
13. Kastan, M.B., Canman, C.E. and Leonard, C.J. (1995) p53, cell cycle control and apoptosis: implications for cancer, Cancer Metastasis Rev. 14, 3-15
14. Jayaraman, L. and Prives, C. (1995) Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus, Cell 81, 1021-1029
15. Lee, S., Elenbaas, B., Levine, A. and Griffith, J. (1995) p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches, Cell 81, 1013-1020
16. Wang, X.W. et al. (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity, Nat. Genet. 10, 188-195
17. Livingstone, L.R. et al. (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53, Cell 70, 923-935
18. Yin, Y.X. et al. (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles, Cell 70, 937-948
19. Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumour suppressor gene: clues to cancer aetiology and molecular pathogenesis, Cancer Res, 54, 4855-4878
20. Parkin, D.M., Pisani, P. and Ferlay, J. (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985, Int. J. Cancer 54, 594-606
21. Béroud, C., Verdier, F. and Soussi, T. p53 gene mutation: software and database, Nucleic Acids Res. (in press)
22. Hamelin, R. et al. (1994) Association of p53 mutations with short survival in colorectal cancer, Gastroenterology 106, 42-48
23. Bergh, J. et al. (1995) Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy, Nat. Med. 10, 1029-1034
24. Hollstein, M. et al. (1994) Database of p53 gene somatic mutations in human tumours and cell lines, Nucleic Acids Res. 22, 3551-3555
25. Cho, Y.J., Gorina, S., Jeffrey, P.D. and Pavletich, N.P. (1994) Crystal structure of a p53 tumour suppressor DNA complex: understanding tumorigenic mutations, Science 265, 346-355
26. Ory, K., Legros, Y., Auguin, C. and Soussi, T. (1994) Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation, EMBO J. 13, 3496-3504
27. Harvey, M. et al. (1995) A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53 deficient mice, Nat. Genet. 9, 305-311
28. Dumaz, N. et al. (1994) Can we predict solar UV radiation as the causal event in human tumours by analysing the mutation spectra of the p53 gene? Mutat. Res. 307, 375-386
29. Tornaletti, S. and Pfeifer, G.P. (1995) Complete and tissue-independent methylation of CpG sites in the p53 gene: implications for mutations in human cancers, Oncogene 10, 1493-1499
30. International Agency for Research on Cancer (1985) Tobacco Smoking (IARC monographs on the evaluation of the carcinogenic risk of chemicals to Human Vol. 38), International Agency for Research on Cancer
31. Takahashi, T. et al. (1989) p53 - a frequent target for genetic abnormalities in lung cancer, Science 246, 491-494
32. Chiba, I. et al. (1990) Mutations in the p53 gene are frequent in primary, resected non-small-cell lung cancer, Oncogene 5, 1603-1610
33. Hsu, I.C. et al. (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas, Nature 350, 427-428
34. Bressac, B., Kew, M., Wands, J. and Ozturk, M. (1991) Selective G-mutation to T-mutation of p53 gene in hepatocellular carcinoma from Southern Africa, Nature 350, 429-431
35. Soussi, T., Caron de Fromentel, C. and May, P. (1990) Structural aspects of the p53 protein in relation to gene evolution, Oncogene 5, 945-952
36. Ozturk, M. et al. (1991) p53 mutation in hepatocellular carcinoma after aflatoxin exposure, Lancet 338, 1356-1359
37. Aguilar, F. et al. (1994) Geographic variation of p53 mutational profile in non-malignant human liver, Science 264, 1317-1319
38. Puisieux, A., Lim, S., Groopman, J. and Ozturk, M. (1991) Selective targeting of p53 gene mutational hotspots in human cancers by aetiologically defined carcinogens, Cancer Res. 51, 6185-6189
39. Brash, D.E. et al. (1991) A role for sunlight in skin cancer - UV-induced p53 mutations in squamous cell carcinoma, Proc. Natl Acad. Sci. USA 88, 10124-10128
40. Ziegler, A. et al. (1994) Sunburn and p53 in the onset of skin cancer, Nature 372, 773-776
41. Hollstein, M. et al. (1994) p53 mutations at A:T base pairs in angiosarcomas of vinyl chloride-exposed factory workers, Carcinogenesis 15, 1-3
42. Taylor, J.A. et al. (1994) p53 mutation hotspot in radon-associated lung cancer, Lancet 343, 86-87
43. Takeshima, Y. et al. (1993) p53 mutations in lung cancers from non-smoking atomic-bomb survivors. Lancet 342, 1520-1521